logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix.

    Article - En anglais

    Fulltext.

    Data from a hospital-based case-control study collected between 1979 and 1988 in 10 participating hospitals in eight countries were analyzed to determine whether use of combined oral contraceptives alters the risks of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix.

    Information on prior use of oral contraceptives, suspected risk factors for cervical cancer, and history of cytologic screening was ascertained from interviews with 271 women with adenocarcinomas, 106 with adenosquamous carcinomas, and a large pool of hospitalized controls, from which 2,887 were matched to the cases included in this report.

    History of smoking and anogenital warts and blood specimens for measurement of herpes simplex and cytomegalovirus antibodies were obtained from subsets of these women, as was a sexual history from a subset of their husbands.

    The epidemiologic features and associations with oral contraceptives were similar for adenocarcinoma and adenosquamous carcinoma.

    For both types combined, risk increased with duration of oral contraceptive use, was highest in recent and current users, and declined with time since cessation of use.

    These trends in risk were strongest for cancers that occurred in women under age 35 years, and the association with risk was somewhat stronger for high compared with low progestin potency products. (...)

    Mots-clés Pascal : Adénocarcinome, Carcinome adénosquameux, Utérus, Toxicité, Contraceptif, Voie orale, Contraception, Epidémiologie, Femme, Homme, Tumeur maligne, Utérus pathologie, Appareil génital femelle pathologie

    Mots-clés Pascal anglais : Adenocarcinoma, Adenosquamous carcinoma, Uterus, Toxicity, Contraceptive, Oral administration, Contraception, Epidemiology, Woman, Human, Malignant tumor, Uterine diseases, Female genital diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0393665

    Code Inist : 002B02U06. Création : 10/04/1997.